The medical centre at Skolkovo and Morozov Hospital: a source of pride for Moscow’s doctors

The medical centre at Skolkovo and Morozov Hospital: a source of pride for Moscow’s doctors
Skolkovo will soon be the home to a medical centre that will not only provide quality, high-tech healthcare, but will train the best specialists for Russia’s healthcare sector. But Moscow is already home to other high-tech medical centres that have already opened their doors or will do so soon.

 Skolkovo’s unique medical project

Science and innovation hub Skolkovo is set to welcome soon the International Medical Centre (MMK by its Russian acronym). It will be equipped with latest high-tech equipment for the most complex operations. The world’s best clinics and doctors will work at the centre. This will create the opportunity to obtain medical treatment and services of kinds seldom seen in Russia previously.

Very soon, people needing high-tech medical services will need to go no further than just beyond the MKAD (Moscow Ring Road). It will take just 20 minutes to reach to international medical centre from central Moscow.

The centre will be divided into an education section, research section, and the medical section proper. The centre will serve as a base for developing new medicines and medical products and carrying out clinical studies of new medical practices. Managing company, MMK Fund, was set up to organise the centre’s activity, as well as a supervisory board, board of trustees, and an expert council. Thorough effort went into developing MMK’s concept, with particular attention given to studying best international practice and analysing the market. One of the world’s top consulting companies, Boston Consulting Group, was brought in to help with this. The concept includes at least 15 international medical institutions that will open over the next 10-15 years, making it possible to treat around 300,000 patients a year.

The first stage of construction involves a new diagnostic centre. It will have an area of 13,000 square metres, of which the Check Up diagnostic department will occupy 3,500 square metres. 

The new centre will house 49 out-patient offices, a four-bed day ward, an express laboratory, a radiation diagnostic department, and an auxiliary services block. The building will be ready for use in the fourth quarter of 2017 and will receive its first patients in the first quarter of 2018. Construction is currently underway.

The centre will have a staff of 133, including 38 doctors. Senior medical personnel will be selected by the Check Up diagnostic department’s operator, Israeli clinic Hadassah Medical.

The second stage of construction will be the treatment building, which will have a total area of 19,000 square metres. It will be completed in the fourth quarter of 2018 and will receive its first patients in the second quarter of 2019.

This building will house a clinical diagnostic laboratory, a 63-bed in-patient facility, an operating block with four operating theatres, a 9-bed intensive care ward, a 36-bed short-stay ward, a four-bed day ward, a central sterilisation department, a 20-bed oncological-urology ward, a 20-bed oncological-gynaecology ward and much more. The in-patient facilities will take patients older than 18. 

The new medicines test centre at the Sklifosovsky Research Institute

Russia’s first unified new medicines test centre will be established at Moscow’s Sklifosovsky Research Institute of Emergency Care. This will free Russian pharmaceutical companies of dependence on foreign laboratories.

The new building will have an area of 9,100 square metres. Construction began in 2012. The finishing work, installation of medical equipment and furniture, and landscaping are currently underway. 

Medicines will be tested according to the Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) international standards. This means that the centre’s employees will be able to ascertain a substance’s effectiveness and safety, study possibilities for wider applications in medicine, identify previously unknown side effects and more.  

The radio-surgery centre at the Sklifosovsky Institute has already started performing complex operations using a Gamma scalpel tool. It is now possible to treat benign and malignant brain tumours without opening the skull. The first operations were a success and do not require in-patient hospitalisation.

Morozov Hospital’s new multipurpose treatment centre

Morozov Hospital’s new multipurpose treatment centre will be completed at the end of 2016. In terms of equipment, treatment methods and hospitalisation conditions for child patients, this new centre will be one of the best in the world. The facility is expected to admit its first patients by early May. The new centre will be able to treat an additional 70,000 children a year.

The 7-storey building has an area of 71,200 square metres. The structure and walls are already in place and the communications systems have been connected. The builders will soon start the finishing work and then the complex medical equipment will be installed. The building will be inaugurated in the first quarter of 2017.

The reception and infectious diseases departments will be on the first floor. The second floor will house the emergency abdominal and infection surgery, otolaryngology and endocrinology departments. The third floor will house the functional diagnostics, endoscopy, traumatology, orthopaedics, scheduled surgery and urology departments. The fourth floor is for the oncology and haematology departments, as well as an intensive therapy section, and the ophthalmology and eye microsurgery departments. The fifth floor is for the bone marrow transplant department and an intensive therapy section, cardio-rheumatology and pulmonology, neurosurgery and neuro-oncology departments with an intensive therapy section. The sixth floor will house the operating theatres, anaesthesiology, intensive care, and radiation diagnostic departments and also the administrative and management section. The seventh floor is the physiotherapy and therapeutic physical culture departments, diagnostic and treatment department and the kitchen and cafeteria. 

The wards will be fitted with alarm buttons.

The perinatal and cardiology centre at Hospital No. 67

The new perinatal and cardiology building at Vorokhobov Hospital No. 67 will open in 2017 and will be one of the biggest perinatal centres in Europe.

The building will be equipped with modern diagnostic equipment such as inhalation, surgical and endoscopic equipment, artificial breathing apparatuses and others. Ultrasound scanners will be used to diagnose cardiac problems in children and mothers at an early stage.

The building will have an area of 52,000 square metres. The building varies in height from three to seven floors. It will also house reception and records sections, a paediatrics section, a childbirth in-patient facility, and a consultation and diagnostic centre for women.

The new building will have a capacity of around 17,000 people a year.

The regional cardiovascular centre in Zelenograd

This spring saw the opening of the regional cardiovascular centre at Hospital No. 3 in Zelenograd. The centre treats people who have suffered heart attacks, strokes or other cardiovascular diseases. These patients previously had to go to Moscow for treatment.

The centre has an X-ray endovascular diagnostic and treatment department, a neurology department for patients with serious blood circulation problems in the brain, an emergency heart surgery department, an intensive care ward for heart patients, a neurosurgery department, a functional diagnostic department and a clinical diagnostic laboratory. The centre is open 24 hours.

Operations can be carried out with the help of 3D modelling of the body’s cavity structures, enabling doctors to perform the most complex actions with the finest precisions, and a Leica microscope makes it possible to carry out operations on the brain’s tiniest blood vessels. An expert level angiographic device makes it possible to reduce radiation treatment levels.

The centre performed its first emergency operation on a patient with acute coronary syndrome on 31 March.